Research
Hormonal
Tirzepatide has demonstrated superior efficacy in promoting weight loss and maintaining a healthy body weight compared to traditional incretin therapies.
Tirzepatide may be a more effective option for weight management in patients with obesity.
StrongSupportsmedium confidence
Tirzepatide, a dual incretin receptor agonist, has demonstrated superior efficacy in promoting weight loss and maintaining a healthy body weight.
Why this rating
The claim is based on a review of selected articles and reports, indicating a strong basis for the assertion.
Source
TIRZEPATIDE - A NEW ERA IN OBESITY TREATMENT? A REVIEW OF THE CURRENT STATE OF KNOWLEDGE
Adam Solarz et al. · International Journal of Innovative Technologies in Social Science · 2025
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →